UFP Technologies, Inc. Receivables, Net, Current
UFP Technologies, Inc. (UFPT) had Receivables, Net, Current of $113.25 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2026-08-06
- 2026-06-30: Receivables, Net, Current $113.25M.
- 2026-03-31: Receivables, Net, Current $98.57M.
- 2025-12-31: Receivables, Net, Current $82.91M.
- 2025-09-30: Receivables, Net, Current $85.18M.
| Period end | Receivables, Net, Current | Receivables, Net, Current as first filed |
|---|---|---|
| 2026-06-30 | $113.25M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $98.57M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $82.91M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $85.18M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $84.93M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $93.78M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $84.68M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $89.15M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $60.98M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $61.25M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $64.45M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $60.97M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $64.09M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $60.14M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $55.12M 10-Q · filed 2024-11-12 | |
| 2022-09-30 | $61.48M 10-Q/A · filed 2022-11-14 | $65.07M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $57.91M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $46.18M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $39.38M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $32.46M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $31.22M 10-Q · filed 2021-08-06 | |
| 2020-12-31 | $26.43M 10-K · filed 2022-03-14 | |
| 2020-03-31 | $30.02M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $28.65M 10-K · filed 2021-03-12 | |
| 2019-06-30 | $30.68M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $29.77M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $28.32M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $30.14M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $30.18M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $29.29M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $21.38M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $22.04M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $22.31M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $21.92M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $21.25M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $22.31M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $23.02M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $20.38M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $17.48M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $19.25M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $19.52M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $18.22M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $16.47M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $18.57M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $17.62M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $18.15M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $17.03M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $17.81M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $18.66M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $18.51M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $17.84M 10-K · filed 2014-03-14 | $17.84M 10-K · filed 2013-03-15 |
| 2012-09-30 | $16.97M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $16.39M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $16.39M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $15.62M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $15.12M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $16.15M 10-Q · filed 2011-08-10 | |
| 2010-12-31 | $14.63M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |